Les meilleurs doctors traitant la maladie suivante : Ostéosarcome - TOP -68 des médecins

Le chef du département est le Dr Netanel Meusher, spécialiste du traitement du cancer des os.

Chef du service d'hématologie pédiatrique.

Dr. Elnur Sahibov is a licensed Radiation Oncologist with 8 years of medical training and clinical experience. He completed his undergraduate and specialization studies at Marmara University Faculty of Medicine. From 2012 to 2016, he focused on advanced radiation oncology techniques.

Dr. Sahibov is known for his expertise in cancer treatment. He has helped improve patient outcomes and uses evidence-based protocols. He is accredited by leading medical institutions and is dedicated to ongoing professional development in oncology.

Elle a fait ses études de médecine en Russie. Après son internat à Berlin, le Dr Steingraeber a exercé comme spécialiste et médecin-chef à la Charité, à l'hôpital Neukölln de Berlin et en radio-oncologie. Le Dr Steingraeber parle couramment le russe. Sa spécialisation clinique inclut le carcinome bronchique et le carcinome du sein.

Service aux membres/comités :

DEGRO, ARO, DKG, AGSMO

Membre de comités interdisciplinaires pour l’élaboration de lignes directrices :

Carcinome de l'œsophage

carcinome anal

Carcinome oropharyngé/hypopharyngé

Thérapie de soutien en oncologie

Elle a terminé sa formation à la Charité de Berlin et est spécialiste en radiothérapie depuis 20 ans. Elle a travaillé comme médecin-chef dans tous les services de la Charité de Berlin et, de 2007 à 2015, elle a été médecin-chef et directrice adjointe de la clinique de la Charité à Berlin. En 2015, elle a été nommée chef du service de radiothérapie de l'hôpital universitaire de Cologne et a dirigé la clinique avec succès jusqu'en 2022. Depuis fin 2022, elle dirige la clinique de radiothérapie privée « RadioOnkologie Vosspalais ». Ses domaines cliniques comprennent la radio-immunothérapie, la thérapie de haute précision, la thérapie multimodale des tumeurs gynécologiques et du carcinome de la prostate.

La professeure Marnitz est membre des directives allemandes et européennes pour le traitement du carcinome de l'endomètre. Elle est également experte externe indépendante du Conseil européen pour le traitement du carcinome du col de l'utérus, de la vulve et du vagin. Plusieurs essais cliniques randomisés ont été menés sous sa direction.

Le professeur Marnitz est membre honoraire de la Société russe d'oncologie gynécologique et membre des sociétés professionnelles DEGRO, ESTRO et ASTRO. En 2024, il présidera le congrès annuel de la Société allemande de radio-oncologie.

Prof. Dr méd. Volker Budach *Prof. Dr med. Volker Budach

Il a terminé ses études de médecine à l'Université d'Essen et a été nommé au département de radiothérapie de l'hôpital de la Charité à Berlin en 1993. Il a dirigé ce département avec succès jusqu'en 2022, fort de près de 40 ans d'expérience professionnelle et de 30 ans d'expérience managériale. Sous la direction du professeur Budach, de nombreuses études cliniques ont été menées, notamment sur le traitement des tumeurs de la tête et du cou. Outre d'autres tumeurs telles que les sarcomes, les carcinomes bronchiques et les carcinomes du sein, ses domaines de spécialisation clinique et scientifique sont également au cœur de ses préoccupations. Le professeur Budach a fondé et co-dirigé pendant de nombreuses années le centre de cancérologie de la Charité. Outre ses fonctions de directeur de clinique, il a également dirigé le Centre Charité 14, qui regroupait les domaines de l'imagerie et de l'oncologie. Le professeur Budach a été président de la Société allemande de radio-oncologie (DEGRO) et président de son congrès. À l'EORTC, il a dirigé le groupe des tumeurs de la tête et du cou pendant de nombreuses années. Il est l'auteur de nombreux articles importants sur l'optimisation de la radiothérapie et de la chimiothérapie dans le traitement des tumeurs de la tête et du cou. Après 30 ans à la tête de la clinique, le professeur Budach a décidé de mettre son expérience en radio-oncologie au service de la clinique RadioOnkologie Vosspalais. Le professeur Budach est membre des associations professionnelles DEGRO, ESTRO et ASTRO.

Dr. Ilker Nihat Okten is a board-certified medical oncologist. He is accredited by the European Society of Medical Oncology (ESMO). Dr. Okten has worked as a sub-investigator in several phase III clinical trials. His work has helped advance cancer treatment. He specializes in chemotherapy, immunotherapy, targeted therapy, hormonal therapy, and palliative care.

He is a member of ESMO, ASCO, and the Turkish Society of Medical Oncology. Dr. Okten has published several articles in oncology. He is active in both research and clinical practice.

Dr. Raj Nagarkar is a leading Surgical Oncologist with 19 years of experience. He has performed over 50,000 cancer surgeries. His main focus areas are Breast and Thoracic Surgical Oncology. He is involved in more than 200 clinical trials and has contributed to many national and international publications.

Dr. Nagarkar trained in Surgical Oncology at Tata Memorial Hospital, Mumbai. He also holds an MRCS from the Royal College of Surgeons, Edinburgh. He teaches DNB Superspecialty Surgical Oncology and Breast Surgery at Maharashtra University of Health Sciences. Dr. Nagarkar is dedicated to improving the quality of life for his patients.

Dr. Sridhar P.S. is a skilled radiation oncologist. He earned his Bachelor of Medicine from Mysore University. He completed his MD in Radiotherapy at Banaras Hindu University. He also holds a Diplomate of the National Board in Radiotherapy. This shows his advanced training and dedication to quality care.

Dr. Sridhar is a member of several professional groups. These include the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology. He is known for his effective cancer treatments and focus on new therapies. His work has made a positive impact in the field of oncology.

Dr. Chaitainya Borde is a nuclear medicine specialist with 12 years of clinical experience. He is skilled in advanced nuclear scans, PET-CT imaging, and nuclear cardiology. He works in both diagnostic and therapeutic nuclear medicine.

Dr. Borde has performed over 30,000 PET scans. He has managed more than 1,000 thyroid cancer patients. He is experienced in radioiodine and Lu-177 RN therapies. He has also published research papers in respected medical journals, showing his dedication to academic work.

Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.

Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.

Dr. Shaunak Valame is an MD in Internal Medicine and holds a DNB in Medical Oncology. He received advanced training at Indraprastha Apollo Hospital in New Delhi. He also worked as a Registrar at Jawaharlal Nehru Cancer Hospital in Bhopal. Dr. Valame has presented his research at international forums, including the Gastrointestinal Cancer Symposium in San Francisco.

He is known for his work in targeted cancer therapies. He has given lectures at the International Winter School of Oncology at AIIMS Bhopal. Dr. Valame is accredited by the American Society of Clinical Oncology. He is committed to advancing cancer research and clinical care.

Hématologue-oncologue pédiatrique, spécialiste en greffe de moelle osseuse

Dr. Kayihan Engin is a Radiation Oncologist. He earned his medical degree from Uludağ University Medical College in 1983. He completed his residency in Radiation Oncology at the Center of Oncology & Nuclear Medicine in Istanbul in 1990. From 1990 to 1994, he pursued a post-doctoral fellowship in Thermoradiotherapy at Thomas Jefferson University in the USA.

Dr. Engin has held key academic and leadership roles. He served as Professor, Chairman, and Faculty Accreditation Coordinator at Uludağ University Medical College from 1991 to 2005. He was also Professor and Director at Anadolu Medical Center between 2004 and 2017. Since 2017, he has led the Oncological Sciences departments at Ceylan International and Medicana Bursa Hospitals. Dr. Engin is known for his work in improving cancer treatment and medical education standards in Turkey.